IRB Committee 1 is responsible for the full review of human subjects research protocols submitted by faculty/staff for all colleges except the C.T. Bauer School of Business and the College of Liberal Arts and Social Sciences (CLASS). Exceptions: The HHP Department of CLASS submits to IRB 1; all FDA-regulated research is also reviewed by IRB 1, regardless of college.
|Submission Deadlines||IRB 1 Meeting Dates|
|Friday, August 4, 2017||Friday, August 18, 2017|
|Friday, September 1, 2017||Friday, September 15, 2017|
|Friday, October 6, 2017||Friday, October 20, 2017|
|Friday, November 3, 2017||Friday, November 17, 2017|
|Wednesday, November 22, 2017||Friday, December 8, 2017|
|Friday, January 5, 2018||Friday, January 19, 2018|
|Friday, February 2, 2018||Friday, February 16, 2018|
|Friday, March 9, 2018||Friday, March 23, 2018|
|Friday, April 6, 2018||Friday, April 20, 2018|
|Friday, May 4, 2018||Friday, May 18, 2018|
|Friday, June 1, 2018||Friday, June 15, 2018|
|Friday, July 6, 2018||Friday, July 20, 2018|
|Friday, August 3, 2018||Friday, August 17, 2018|
*Dates are subject to change without notice if circumstances require rescheduling.
Protocols falling under an expedited category and involving no more than minimal risk, as well as minor changes in approved full board protocols, may be reviewed under an expedited process. The Chair of IRB 1 either reviews or delegates the review to one or more experienced IRB members, who review the protocol under applicable regulations and either approve or require modifications to the protocol prior to approval. An expedited reviewer may not disapprove a protocol, but may forward to the fully convened committee for further determination if warranted. Expedited submissions are considered on a rolling basis, thus turnaround time for these submissions is expected to be quicker than for protocols undergoing full board review.
Protocols falling under an exempt category defined under the federal regulations require administrative review by the IRB office to ensure that basic ethical principles, such as confidentiality of data and obtaining informed consent where applicable, are addressed. Applications for exempt protocols are reviewed by IRB staff on a rolling basis, thus turnaround time for these submissions is expected to be quicker than for protocols undergoing full board review.